Summary
- Current Price
- As of today, PTGX price is $103.78, up +0.11% on
- Current Price All-Time High
- PTGX price is currently -3.76% below its historical high of $107.84 set on
- Market Cap
- PTGX current market cap is $6B, up +117.35% over the past 365 days
- PE Ratio
- PTGX PE ratio is unknown
- Revenue
- PTGX current annual revenue is $46.02M, down -89.41% year-over-year
- Next Earnings
- The next earnings release for PTGX is on
Profile
| Metric | Value |
|---|---|
| Full Name | Protagonist Therapeutics, Inc. |
| Ticker | NASDAQ: PTGX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | protagonist-inc.com |
| Employees | 124 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $103.78 | |
| Price, 1D Change | +0.11% | |
| $6B | ||
| - | ||
| - | ||
| 0.39 | ||
| $46M | ||
| Revenue, 1Y Change | -89.41% | |
| -$2.05 | ||
| EPS, 1Y Change | -148.41% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$2.05 | ||
| EPS Estimate | N/A | $2.77 |
| EPS Est. Change | N/A | +235.49% |
| $46.02M | ||
| Revenue Estimate | N/A | $441.78M |
| Revenue Est. Change | N/A | +860.05% |
| Current Price | $103.78 | |
| Price Target | - | $112.00 |
| Price Tgt. Change | - | +7.92% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.63 | $4.23 | +60.61% | |
| -$1.87 | -$2.05 | -9.29% | |
| $2.77 | N/A | +235.49% | |
| -$0.43 | N/A | +78.79% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $320.75M | $434.43M | +35.44% | |
| $50.48M | $46.02M | -8.84% | |
| $441.78M | N/A | +860.05% | |
| $155.59M | N/A | +238.12% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $103.78 | |
| $74.87 | ||
| SMA 200 vs Price | -27.85% | |
| $90.62 | ||
| SMA 50 vs Price | -12.68% | |
| 0.39 | ||
| $4.63 | ||
| 62.06 | ||
| 45.55% | ||
| 50.20% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $46.02M | ||
| -$2.05 | ||
| $44.79M | ||
| 97.34% | ||
| -$158.13M | ||
| -343.63% | ||
| -$130.15M | ||
| -282.83% | ||
| -$156.90M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.02 | ||
| 12.71 | ||
| 12.71 | ||
| - | ||
| 4 | ||
| 69.80 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 140.99 | ||
| 10.55 | ||
| -37.81 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $614.71M | ||
| $567.36M | ||
| $669.89M | ||
| $577.57M | ||
| $55.19M | ||
| $45.44M | ||
| $10.32M | ||
| $2.28M | ||
| $5.34M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $176.17M | ||
| $202.92M | ||
| $1.23M | ||
| $0.00 | ||
| $1.28M | ||
| $0.00 | ||
| $838.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $57.67M | ||
| -$49.33M | ||
| $22.86M | ||
| $1.59M | ||
| $56.08M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Leerink Partners | → | |
| JP Morgan | → | |
| Citigroup | → | |
| Barclays | → | |
| Goldman Sachs | → | |
| TD Cowen | → | |
| Citizens | → | |
| Barclays | → | |
| Jefferies | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with PTGX
FAQ
What is the ticker symbol for Protagonist Therapeutics, Inc.?
The ticker symbol for Protagonist Therapeutics, Inc. is NASDAQ:PTGX
Does Protagonist Therapeutics, Inc. pay dividends?
No, Protagonist Therapeutics, Inc. does not pay dividends
What sector is Protagonist Therapeutics, Inc. in?
Protagonist Therapeutics, Inc. is in the Healthcare sector
What industry is Protagonist Therapeutics, Inc. in?
Protagonist Therapeutics, Inc. is in the Biotechnology industry
What country is Protagonist Therapeutics, Inc. based in?
Protagonist Therapeutics, Inc. is headquartered in United States
When did Protagonist Therapeutics, Inc. go public?
Protagonist Therapeutics, Inc. initial public offering (IPO) was on August 11, 2016
Is Protagonist Therapeutics, Inc. in the S&P 500?
No, Protagonist Therapeutics, Inc. is not included in the S&P 500 index
Is Protagonist Therapeutics, Inc. in the NASDAQ 100?
No, Protagonist Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Protagonist Therapeutics, Inc. in the Dow Jones?
No, Protagonist Therapeutics, Inc. is not included in the Dow Jones index
When was Protagonist Therapeutics, Inc. last earnings report?
Protagonist Therapeutics, Inc.'s most recent earnings report was on February 25, 2026
When does Protagonist Therapeutics, Inc. report earnings?
The next expected earnings date for Protagonist Therapeutics, Inc. is May 6, 2026
Data Sources & References
- PTGX Official Website www.protagonist-inc.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1377121/000110465926019696/0001104659-26-019696-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1377121/000110465926019696/0001104659-26-019696-index.htm
- PTGX Profile on Yahoo Finance finance.yahoo.com/quote/PTGX
- PTGX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ptgx